|
1
|
Li F, Ackermann EJ, Bennett CF, Rothermel
AL, Plescia J, Tognin S, Villa A, Marchisio PC and Altieri DC:
Pleiotropic cell-division defects and apoptosis induced by
interference with survivin function. Nat Cell Biol. 1:461–466.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li F and Ling X: Survivin study: An update
of “what is the next wave”? J Cell Physiol. 208:476–486. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Knauer SK, Mann W and Stauber RH:
Survivin's dual role: An export's view. Cell Cycle. 6:518–521.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Andersen MH, Svane IM, Becker JC and
Straten PT: The universal character of the tumor-associated antigen
survivin. Clin Cancer Res. 13:5991–5994. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen P, Li J, Ge LP, Dai CH and Li XQ:
Prognostic value of survivin, X-linked inhibitor of apoptosis
protein and second mitochondria-derived activator of caspases
expression in advanced non-small-cell lung cancer patients.
Respirology. 15:501–509. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xiaoyuan C, Longbang C, Jinghua W,
Xiaoxiang G, Huaicheng G, Qun Z and Haizhu S: Survivin: A potential
prognostic marker and chemoradiotherapeutic target for colorectal
cancer. Ir J Med Sci. 179:327–335. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Youssef NS, Hewedi IH and Abd Raboh NM:
Immunohistochemical expression of survivin in breast carcinoma:
Relationship with clinicopathological parameters, proliferation and
molecular classification. J Egypt Natl Canc Inst. 20:348–357.
2008.PubMed/NCBI
|
|
8
|
Wang TT, Qian XP and Liu BR: Survivin:
Potential role in diagnosis, prognosis and targeted therapy of
gastric cancer. World J Gastroenterol. 13:2784–2790.
2007.PubMed/NCBI
|
|
9
|
Ito T, Shiraki K, Sugimoto K, Yamanaka T,
Fujikawa K, Ito M, Takase K, Moriyama M, Kawano H, Hayashida M, et
al: Survivin promotes cell proliferation in human hepatocellular
carcinoma. Hepatology. 31:1080–1085. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mita AC, Mita MM, Nawrocki ST and Giles
FJ: Survivin: Key regulator of mitosis and apoptosis and novel
target for cancer therapeutics. Clin Cancer Res. 14:5000–5005.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miura K, Fujibuchi W, Ishida K, Naitoh T,
Ogawa H, Ando T, Yazaki N, Watanabe K, Haneda S, Shibata C and
Sasaki I: Inhibitor of apoptosis protein family as diagnostic
markers and therapeutic targets of colorectal cancer. Surg Today.
41:175–182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sah NK, Khan Z, Khan GJ and Bisen PS:
Structural, functional and therapeutic biology of survivin. Cancer
Lett. 244:164–171. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stauber RH, Mann W and Knauer SK: Nuclear
and cytoplasmic survivin: Molecular mechanism, prognostic, and
therapeutic potential. Cancer Res. 67:5999–6002. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fornerod M, Ohno M, Yoshida M and Mattaj
IW: CRM1 is an export receptor for leucine-rich nuclear export
signals. Cell. 90:1051–1060. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fukuda M, Asano S, Nakamura T, Adachi M,
Yoshida M, Yanagida M and Nishida E: CRM1 is responsible for
intracellular transport mediated by the nuclear export signal.
Nature. 390:308–311. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ossareh-Nazari B, Bachelerie F and
Dargemont C: Evidence for a role of CRM1 in signal-mediated nuclear
protein export. Science. 278:141–144. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stade K, Ford CS, Guthrie C and Weis K:
Exportin 1 (Crm1p) is an essential nuclear export factor. Cell.
90:1041–1050. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang WY, Yue L, Qiu WS, Wang LW, Zhou XH
and Sun YJ: Prognostic value of CRM1 in pancreas cancer. Clin
Invest Med. 32:E315–E321. 2009.PubMed/NCBI
|
|
19
|
Inoue H, Kauffman M, Shacham S, Landesman
Y, Yang J, Evans CP and Weiss RH: CRM1 blockade by selective
inhibitors of nuclear export attenuates kidney cancer growth. J
Urol. 189:2317–2326. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Noske A, Weichert W, Niesporek S, Röske A,
Buckendahl AC, Koch I, Sehouli J, Dietel M and Denkert C:
Expression of the nuclear export protein chromosomal region
maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian
cancer. Cancer. 112:1733–1743. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van der Watt PJ, Maske CP, Hendricks DT,
Parker MI, Denny L, Govender D, Birrer MJ and Leaner VD: The
Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed
in cervical cancer and are critical for cancer cell survival and
proliferation. Int J Cancer. 124:1829–1840. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang X, Cheng L, Yao L, Ren H, Zhang S,
Min X, Chen X, Zhang J and Li M: Involvement of chromosome region
maintenance 1 (CRM1) in the formation and progression of esophageal
squamous cell carcinoma. Med Oncol. 31:1552014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou F, Qiu W, Yao R, Xiang J, Sun X, Liu
S, Lv J and Yue L: CRM1 is a novel independent prognostic factor
for the poor prognosis of gastric carcinomas. Med Oncol.
30:7262013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hama H, Tabuchi T, Ito Y, Fukushima W,
Matsunaga I, Miyashiro I and Nakayama T: Smoking behavior and
participation in screening for lung, gastric, and colorectal
cancers. Nihon Koshu Eisei Zasshi. 63:126–134. 2016.(In Japanese).
PubMed/NCBI
|
|
25
|
Nishimoto H, Katanoda K, Sato N, Sobue T
and Mikami H: Cancer statistics in Japan 2014Wakao F: Center for
Cancer Control and Information Services. National Cancer Center;
2015, (In Japanese).
|
|
26
|
Shintani M, Sangawa A, Yamao N and
Kamoshida S: Immunohistochemical expression of nuclear and
cytoplasmic survivin in gastrointestinal carcinoma. Int J Clin Exp
Pathol. 6:2919–2927. 2013.PubMed/NCBI
|
|
27
|
Hutten S and Kehlenbach RH: CRM1-mediated
nuclear export: To the pore and beyond. Trends Cell Biol.
17:193–201. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Knauer SK, Krämer OH, Knösel T, Engels K,
Rödel F, Kovács AF, Dietmaier W, Klein-Hitpass L, Habtemichael N,
Schweitzer A, et al: Nuclear export is essential for the
tumor-promoting activity of survivin. FASEB J. 21:207–216. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stauber RH, Rabenhorst U, Rekik A, Engels
K, Bier C and Knauer SK: Nucleocytoplasmic shuttling and the
biological activity of mouse survivin are regulated by an active
nuclear export signal. Traffic. 7:1461–1472. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Japanese Gastric Cancer Association, .
Japanese classification of gastric carcinoma. 3rd English edition.
Gastric Cancer. 14:101–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Japanese Society for Cancer of the Colon
and Rectum, . Japanese Classification of Colorectal Carcinoma. 2nd
English edition. Kanehara & Co., Ltd.; Tokyo: 2009
|
|
32
|
Shen A, Wang Y, Zhao Y, Zou L, Sun L and
Cheng C: Expression of CRM1 in human gliomas and its significance
in p27 expression and clinical prognosis. Neurosurgery. 65:153–159.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yao Y, Dong Y, Lin F, Zhao H, Shen Z, Chen
P, Sun YJ, Tang LN and Zheng SE: The expression of CRM1 is
associated with prognosis in human osteosarcoma. Oncol Rep.
21:229–235. 2009.PubMed/NCBI
|
|
34
|
Wang S, Han X, Wang J, Yao J and Shi Y:
Antitumor effects of a novel chromosome region maintenance 1 (CRM1)
inhibitor on non-small cell lung cancer cells in vitro and in mouse
tumor xenografts. PLoS One. 9:e898482014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yashiroda Y and Yoshida M:
Nucleo-cytoplasmic transport of proteins as a target for
therapeutic drugs. Curr Med Chem. 10:741–748. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang K, Wang M, Tamayo AT, Shacham S,
Kauffman M, Lee J, Zhang L, Ou Z, Li C, Sun L, et al: Novel
selective inhibitors of nuclear export CRM1 antagonists for therapy
in mantle cell lymphoma. Exp Hematol. 41:67–78.e4. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Knauer SK, Bier C, Habtemichael N and
Stauber RH: The Survivin-Crm1 interaction is essential for
chromosomal passenger complex localization and function. EMBO Rep.
7:1259–1265. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nguyen KT, Holloway MP and Altura RA: The
CRM1 nuclear export protein in normal development and disease. Int
J Biochem Mol Biol. 3:137–151. 2012.PubMed/NCBI
|
